Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch

This study has been completed.
Information provided by (Responsible Party):
ALK-Abelló A/S Identifier:
First received: August 27, 2010
Last updated: February 7, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)